nach oben

Erschienen in:

09.02.2023 | Congress Report ISHL 2022

A GLOBAL CONGRESS DIGEST ON IMMUNE-DIRECTED THERAPIES IN HODGKIN LYMPHOMA. Report from the International Symposium on Hodgkin lymphoma (ISHL12), 22nd–24th October 2022 (hybrid)

Einloggen, um Zugang zu erhalten

Titel: A GLOBAL CONGRESS DIGEST ON IMMUNE-DIRECTED THERAPIES IN HODGKIN LYMPHOMA. Report from the International Symposium on Hodgkin lymphoma (ISHL12), 22nd–24th October 2022 (hybrid)
Publikationsdatum: 09.02.2023
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe Sonderheft 11/2022
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-023-00874-5